Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Operating Margin (2017 - 2020)

Historic Operating Margin for Cogent Biosciences (COGT) over the last 4 years, with Q3 2020 value amounting to 18333.01%.

  • Cogent Biosciences' Operating Margin fell 171530100.0% to 18333.01% in Q3 2020 from the same period last year, while for Dec 2020 it was 1044.33%, marking a year-over-year decrease of 9013100.0%. This contributed to the annual value of 10887.1% for FY2025, which is N/A changed from last year.
  • As of Q3 2020, Cogent Biosciences' Operating Margin stood at 18333.01%, which was down 171530100.0% from 1402.08% recorded in Q2 2020.
  • In the past 5 years, Cogent Biosciences' Operating Margin ranged from a high of 14.65% in Q4 2019 and a low of 18333.01% during Q3 2020
  • In the last 4 years, Cogent Biosciences' Operating Margin had a median value of 332.18% in 2017 and averaged 1640.08%.
  • Examining YoY changes over the last 5 years, Cogent Biosciences' Operating Margin showed a top increase of 3005100bps in 2020 and a maximum decrease of -171530100bps in 2020.
  • Cogent Biosciences' Operating Margin (Quarter) stood at 324.07% in 2017, then rose by 27bps to 236.64% in 2018, then skyrocketed by 106bps to 14.65% in 2019, then tumbled by -125223bps to 18333.01% in 2020.
  • Its Operating Margin was 18333.01% in Q3 2020, compared to 1402.08% in Q2 2020 and 87.34% in Q1 2020.